Compare CISS & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CISS | SPRC |
|---|---|---|
| Founded | 2022 | 2004 |
| Country | Greece | Israel |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.0M |
| IPO Year | N/A | N/A |
| Metric | CISS | SPRC |
|---|---|---|
| Price | $0.25 | $1.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 875.3K | ★ 3.5M |
| Earning Date | 11-18-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,613,149.00 | $1,306,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.65 | ★ N/A |
| Revenue Growth | N/A | ★ 187.98 |
| 52 Week Low | $0.23 | $1.55 |
| 52 Week High | $11.52 | $37.59 |
| Indicator | CISS | SPRC |
|---|---|---|
| Relative Strength Index (RSI) | 15.99 | 36.47 |
| Support Level | $1.76 | $1.55 |
| Resistance Level | $1.94 | $2.26 |
| Average True Range (ATR) | 0.11 | 0.32 |
| MACD | -0.12 | 0.04 |
| Stochastic Oscillator | 0.97 | 16.39 |
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.